SECsense Logo

Axsome Therapeutics, Inc. 8-K Report: Key Insights from January 13, 2025 Filing

$AXSM
Form 8-K
Filed on: 2025-01-13
Source
Axsome Therapeutics, Inc. 8-K Report: Key Insights from January 13, 2025 Filing

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: Axsome Therapeutics, Inc.
  • CIK (Central Index Key): 0001579428
  • SEC File Number: 001-37635
  • EIN (Employer Identification Number): 45-4241907
  • Address: One World Trade Center, 22nd Floor, New York, NY 10007
  • Phone Number: (212) 332-3241
  1. Filing Details:
  • Filing Type: 8-K (a report of unscheduled material events or corporate changes)
  • Filing Date: January 13, 2025
  1. Stock Information:
  • Common Stock: Par Value of $0.0001 per share
  • Ticker Symbol: AXSM
  • Exchange: NASDAQ
  1. Period of Report:
  • Start Date: January 13, 2025
  • End Date: January 13, 2025

Insights:

  • The filing is an 8-K, which indicates that Axsome Therapeutics is reporting a significant event that may be of interest to shareholders and the SEC.
  • The report is for a single day, which suggests it may relate to an event that occurred on that date.
  • The documented address and contact information provides a point of reference for investors or regulators seeking further information about the company's operations.
  • The par value and ticker symbol are essential for understanding the company's stock structure and trading details on the NASDAQ.

Overall, this filing provides a snapshot of Axsome Therapeutics, including critical identifiers, the nature of the filing, and its stock information, all of which are significant for investors and analysts.